Format

Send to

Choose Destination
See comment in PubMed Commons below
Allergy Asthma Immunol Res. 2011 Jan;3(1):3-10. doi: 10.4168/aair.2011.3.1.3. Epub 2010 Aug 20.

Aspirin-exacerbated respiratory disease: evaluation and management.

Author information

  • 1Division of Allergy, Asthma & Immunology, Naval Medical Center Portsmouth, Portsmouth, VA, USA.

Abstract

The clinical syndrome of aspirin-exacerbated respiratory disease (AERD) is a condition where inhibition of cyclooxygenase-1 (COX-1) induces attacks of upper and lower airway reactions, including rhinorrhea and varying degrees of bronchospasm and laryngospasm. Although the reaction is not IgE-mediated, patients can also present with anaphylactic hypersensitivity reactions, including hypotension, after exposure to COX-1 inhibiting drugs. All patients with AERD have underlying nasal polyps and intractable sinus disease which may be difficult to treat with standard medical and surgical interventions. This review article focuses on the management of AERD patients with a particular emphasis on aspirin desensitization and continuous treatment with aspirin.

KEYWORDS:

Aspirin-exacerbated respiratory disease; Samter's triad; aspirin desensitization; aspirin sensitivity; asthma; chronic sinusitis; nasal polyps

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease Icon for PubMed Central
    Loading ...
    Write to the Help Desk